GloPID-R
Nonprofit Organization Management - Lyon, Auvergne-Rhône-Alpes, France
GloPID-R Employees
GloPID-R Details
We are a global consortium of funding organizations investing in research related to new or re-emerging infectious diseases. The COVID-19 pandemic has brought our key priorities into sharper focus: increasing research preparedness, facilitating a rapid response, and strengthening collaboration and coordination among funders and other key stakeholders. The collaborative work that GloPID-R has accomplished since 2015, with a particular focus on preparedness and response to outbreaks including Ebola and Zika, allowed us to act swiftly and deliver a coordinated response to the coronavirus (COVID-19) outbreak as of January 2020. GloPID-R's Scientific Advisory Group (SAG) supports efficiency in global research investments by providing recommendations in line with WHO priorities, to ensure funding will go where it is needed most. Members & GovernanceGloPID-R currently has 32 members and 4 observers. It is governed by a six-member international Board of Chairs representing: • AMED, Japan Agency for Medical Research and Development• ANRS, Emerging Infectious Diseases Agency of INSERM• CIHR, Canadian Institutes of Health Research• The European Commission• SAMRC, South African Medical Research Council• Wellcome Trust The work of the GloPID-R Secretariat is supported by the European Union's Horizon 2020 Research and Innovation Programme under GloPID-R SEC 2 Grant Agreement no. 874667.
GloPID-R Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly